No abstract available
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Chemotherapy, Adjuvant
-
Consensus Development Conferences as Topic
-
Disease-Free Survival
-
Female
-
Humans
-
Lymphatic Metastasis
-
Radiotherapy, Adjuvant
-
Risk
-
Survival Analysis
-
Time Factors
Substances
-
Antineoplastic Agents, Hormonal